Preferred Pharmaceuticals, Inc recalls Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250
Preferred Pharmaceuticals recalls 320mg Valsartan Tablets due to detected carcinogen impurity in manufacturing. Affected lots include NDC 68788-6882-9, Lot # G2017F. Consumers should contact the company for details.
Recall notice
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Contact the company & request your remedy
What happened, in plain English
Preferred Pharmaceuticals is recalling 320mg Valsartan Tablets because a carcinogen impurity was found in the drug product. This could pose a health risk with long-term use, especially for people taking the medication regularly. Read more at govinfonow.com/recall/39725-preferred-pharmaceuticals-valsartan-tablets-320mg-recall-carcinogen-impurity-detected.
Source Summary by GovInfoNow · govinfonow.com/recall/39725-preferred-pharmaceuticals-valsartan-tablets-320mg-recall-carcinogen-impurity-detected · Updated October 6, 2026 · FDA enforcement record: FDA #D-1107-2018
Cite this page
“Preferred Pharmaceuticals Valsartan Tablets 320mg Recall: Carcinogen Impurity Detected.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39725-preferred-pharmaceuticals-valsartan-tablets-320mg-recall-carcinogen-impurity-detected. Based on FDA recall #D-1107-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1107-2018%22&limit=1).
Why it’s dangerous
The drug product contains a carcinogen impurity that was detected during manufacturing. This impurity could potentially cause cancer with long-term use, especially for individuals taking the medication regularly.
Who’s affected
People who have been prescribed Valsartan Tablets by a doctor and are using the recalled product. Those with chronic conditions requiring long-term medication are at higher risk.
How to tell if you have this one
Check for the product name 'Valsartan Tablets USP 320 mg, 90-count' in a plastic child-resistant bottle. The lot number is G2017F and NDC code 68788-6882-9.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Contact Manufacturer
Reach out to Preferred Pharmaceuticals at 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807 for specific recall details and instructions.
Questions people ask
Is this product safe to use?
The recall states a carcinogen impurity was detected, which could pose a health risk with long-term use. The manufacturer advises contacting them for specific guidance.
How can I check if my product is affected?
Check for the product name 'Valsartan Tablets USP 320 mg, 90-count' in a plastic child-resistant bottle with lot number G2017F and NDC code 68788-6882-9.
What should I do if I have the recalled product?
Contact Preferred Pharmaceuticals at 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807 for specific instructions on what to do with the product.
Contact Preferred Pharmaceuticals
We’ve drafted a message you can send Preferred Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1107-2018 — Preferred Pharmaceuticals Preferred Pharmaceuticals Hello, I own a Preferred Pharmaceuticals that is covered by recall D-1107-2018 from Preferred Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1107-2018 (August 15, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1107-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.